A practical guide for providers on helping patients locate Asmanex during the shortage. Covers availability tools, workflow tips, and alternative strategies.
The Asmanex (mometasone furoate) shortage has been a persistent headache for providers and patients alike. When a patient calls your office saying their pharmacy is out of Asmanex — again — it creates a cascade of work: phone calls, prior authorizations, prescription changes, and worried patients going without their controller inhaler.
This guide provides a practical, step-by-step framework for helping your patients maintain access to Asmanex or a suitable alternative during ongoing supply constraints. The goal is to reduce callbacks, prevent gaps in therapy, and streamline the process for your clinical team.
As of early 2026, the Asmanex supply situation is mixed:
Availability changes frequently and varies by region, distributor, and pharmacy. What's out of stock this week may be available next week — and vice versa.
Understanding the root causes helps you communicate more effectively with patients and plan ahead:
The single most impactful thing you can do is verify that a pharmacy has Asmanex in stock before sending the prescription. This prevents the frustrating cycle of prescription sent → pharmacy calls to say it's unavailable → patient calls your office → new prescription needed.
Medfinder for Providers lets you search real-time pharmacy availability by medication and location. Integrating a quick availability check into your prescribing workflow can dramatically reduce callbacks and patient frustration.
For every patient on Asmanex, document a preferred alternative ICS in the medical record. This way, if the pharmacy calls to say Asmanex is unavailable, your team can quickly authorize a switch without requiring a full provider review.
Recommended alternatives (in approximate order of availability and cost):
Include the equivalent dose in your note. See the provider shortage briefing for a dose equivalence reference.
Run a panel report for patients currently prescribed Asmanex. Proactively reach out — via patient portal message or phone call — to:
This proactive approach prevents emergency calls and reduces the risk of patients going without their controller medication.
If a patient's usual pharmacy is out of stock, consider these alternatives:
Encourage patients to use Medfinder to find nearby pharmacies with stock.
With no generic available, cost can be a significant barrier — especially for uninsured or underinsured patients:
For patients where cost is the primary barrier, generic fluticasone propionate (as low as $30–$80 with coupons) may be the most practical solution. For a comprehensive guide, share: How to Save Money on Asmanex.
When substituting, use these approximate dose equivalences:
Follow up in 2–4 weeks after any ICS switch to reassess asthma control. Document ACT scores or spirometry as clinically appropriate.
The Asmanex shortage is an operational challenge, but with the right systems in place, it doesn't have to result in gaps in patient care. The combination of real-time availability tools, documented substitution preferences, proactive patient outreach, and streamlined team workflows can keep your patients' asthma controlled even when their preferred medication is hard to find.
For the latest clinical data on the shortage, see our provider shortage briefing.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
